Pfizer: Vaccine to Combat COVID and Influenza

The American pharmaceutical company "Pfizer" has announced that it is currently testing a vaccine that can fight both the "Corona" and "influenza" viruses simultaneously, amidst many people's reluctance to receive traditional vaccinations. The British newspaper "Daily Mail" reported that clinical trials on the vaccine, which combats the "Corona" virus causing "COVID-19" and influenza, have begun, noting that the first patient received the vaccine, which targets both viruses, earlier this week. Pfizer has recruited 180 individuals aged 18 to 64 years to conduct these trials, and their cases will be monitored over the next six months and compared with individuals in a group that did not receive the vaccine.